Levomepromazine-d3 Sulfoxide

• CAT Number: R025113
• CAS Number: 7606-29-3
• Molecular Formula: C₁₉H₂₁D₃N₂O₂S
• Molecular Weight: 347.49
• Purity: ≥95%
• Synonyms: (-)-10-[3-(Dimethylamino)-2-methylpropyl]-2-methoxy-phenothiazine 5-Oxide; Levomepromazine 5-Sulfoxide; Levopromazine Sulfoxide; Methotrimeprazine 5-Sulfoxide; Methotrimeprazine Sulfoxide
• Storage: -20°C
• IUPAC Name: (2S)-3-(2-methoxy-5-oxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
• InChI: InChI=1S/C19H24N2O2S/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)24(22)19-10-9-15(23-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-,24?/m0/s1
• InChIKey: CUJAZGOWDHBZEI-LNYMIDHXSA-N
• SMILES: C[C@H](CN1C2=CC=CC=C2S(=O)C3=C1C=C(C=C3)OC)CN(C)C

Levomepromazine-d3 Sulfoxide is a deuterated form of levomepromazine sulfoxide, a metabolite of levomepromazine, an antipsychotic drug used for treating schizophrenia and severe anxiety. The three deuterium atoms enhance its utility in pharmacokinetic and metabolic studies, allowing for precise tracking and analysis through NMR spectroscopy and mass spectrometry. This compound aids researchers in understanding the drug’s metabolism, including its absorption, distribution, metabolism, and excretion (ADME) processes. Levomepromazine-d3 Sulfoxide is crucial for optimizing therapeutic regimens, studying drug interactions, and improving the safety and efficacy of antipsychotic treatments.